Scientists in Japan synthesized enhanced vitamin K compounds that appear to promote regeneration of neurons in laboratory models.
The researchers modified molecular structures to increase potency compared with naturally occurring forms of the vitamin.
Early experiments suggest the derivatives may support repair pathways relevant to neurodegenerative conditions such as Alzheimer’s and Parkinson’s disease.
The work remains preclinical, and investigators cautioned that animal results do not yet translate directly into approved therapies for patients.
Neurology specialists said the findings warrant further study into dosing, safety and delivery methods before human trials can be considered.
Vitamin K is already studied for roles in blood clotting, and the Japanese team focused on modified forms that cross the blood-brain barrier more effectively.
Animal models of neurodegeneration showed improved neuronal survival markers after treatment with the synthesized compounds in controlled experiments.
Pharmaceutical development would require toxicity screening and phased human studies before any therapy could reach Alzheimer’s or Parkinson’s patients.
Peer institutions in neurodegeneration research will attempt replication using independent animal models before human safety studies proceed.
Funding agencies reviewing the vitamin K derivative work noted its potential relevance to multiple age-related neurological conditions.
Collaborating laboratories will test whether the supercharged vitamin K compounds maintain stability during formulation steps required for eventual clinical development.
Japanese researchers synthesized new vitamin K derivatives that could stimulate neural regeneration offering hope for Alzheimer’s and Parkinson’s patients.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.sciencedaily.com/news/